PillOTC · Tablet · Oral
Cetirizine
Cetirizine Hydrochloride
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.065
Latest avg · Jul 22, 2026
-9%
Since Dec 17, 2025
3
Active US suppliers
89%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
340
Rx · 2026 Q1
12K
Units dispensed
4
Quarters · since 2025 Q2
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| GLENMARK THERAPEUTICS INC., USA | unknown | 36 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 6 | SUPPLYING |
| Strategic Sourcing Services LLC | unknown | 5 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 13, 2025RECALLRecall (Class II): Cetirizine Hydrochloride Tablets, USP, 10mg, 365-count packs, Rx Only, Manufactured for: Glenmark Therapeutics Inc., Di…
CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide